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to the improvement of geraniol production 
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Abstract 
Background: Microbial production of monoterpenes provides a promising substitute for traditional chemical-based 
methods, but their production is lagging compared with sesquiterpenes. Geraniol, a valuable monoterpene alcohol, 
is widely used in cosmetic, perfume, pharmaceutical and it is also a potential gasoline alternative. Previously, we 
constructed a geraniol production strain by engineering the mevalonate pathway together with the expression of a 
high-activity geraniol synthase.
Results: In this study, we further improved the geraniol production through reducing the endogenous metabolism 
of geraniol and controlling the precursor geranyl diphosphate flux distribution. The deletion of OYE2 (encoding an 
NADPH oxidoreductase) or ATF1 (encoding an alcohol acetyltransferase) both involving endogenous conversion of 
geraniol to other terpenoids, improved geraniol production by 1.7-fold or 1.6-fold in batch fermentation, respectively. 
In addition, we found that direct down-regulation of ERG20 expression, the branch point regulating geranyl diphos-
phate flux, does not improve geraniol production. Therefore, we explored dynamic control of ERG20 expression to 
redistribute the precursor geranyl diphosphate flux and achieved a 3.4-fold increase in geraniol production after 
optimizing carbon source feeding. Furthermore, the combination of dynamic control of ERG20 expression and OYE2 
deletion in LEU2 prototrophic strain increased geraniol production up to 1.69 g/L with pure ethanol feeding in fed-
batch fermentation, which is the highest reported production in engineered yeast.
Conclusion: An efficient geraniol production platform was established by reducing the endogenous metabolism of 
geraniol and by controlling the flux distribution of the precursor geranyl diphosphate. The present work also provides 
a production basis to synthesis geraniol-derived chemicals, such as monoterpene indole alkaloids.
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Background
In nature, isoprenoids are a large group of diverse com-
pounds, that are biosynthesized via both the cyto-
solic mevalonate (MVA) pathway and the plastidial 
2C-methyl-D-erythrtiol 4-phosphate (MEP) pathway in 
plants and most bacteria, or the mevalonate (MVA) path-
way in animals and eukaryotes [1]. The universal precur-
sors of isoprenoids, isopentenyl diphosphate (IPP) and 
dimethylallyl pyrophosphate (DMAPP), are derived from 
both pathways. Among them, monoterpenes are a par-
ticularly interesting subset of this family, which has been 
widely used as flavors, fragrances and pharmaceuticals as 
well as potential fuels [2, 3]. Traditionally, monoterpenes 
Open Access
Microbial Cell Factories
*Correspondence:  houjin@sdu.edu.cn; bxm@sdu.edu.cn 
1 State Key Laboratory of Microbial Technology, School of Life Science, 
Shandong University, Jinan 250100, China
Full list of author information is available at the end of the article
Page 2 of 11Zhao et al. Microb Cell Fact  (2017) 16:17 
and their derivatives are produced from plants in low 
amounts, and the extraction process from plants is costly 
and highly dependent on the availability of raw materi-
als. Engineering microbial organisms for monoterpene 
synthesis provides a potential effective route for their 
production.
Monoterpene geraniol (trans-3,7-dimethyl-2,6-octa-
dien-1-ol; C10H18O), an acyclic monoterpene, is typically 
generated from aromatic plants and has many applica-
tions in perfume, pharmaceutical, and other chemical 
industries [4]. Geraniol is also considered as a promis-
ing biofuel due to its high energy content, low hygrosco-
picity and low volatility in comparison with ethanol [5]. 
In addition, a recent study reported that geraniol can 
undergo an 11-step heterologous biosynthetic pathway 
to form strictosidine, which is the common intermedi-
ate for production of the anticancer agent monoterpene 
indole alkaloids (MIAs) [6]. Given its low yield in aro-
matic plants, geraniol has been successfully synthesized 
in Escherichia coli and Saccharomyces cerevisiae through 
metabolic engineering strategies [7–11]. S. cerevisiae has 
been used widely as a cell factory to produce a diversity 
of terpenes, and many of them have achieved signifi-
cant yields [12–15]. However, monoterpene production 
has been achieved only at low levels thus far [8, 16, 17]. 
There are two challenges for high level monoterpenes 
production. One is the availability of intracellular geranyl 
diphosphate (GPP) precursor, and the other is the toxicity 
of monoterpenes to cells [18, 19]. Most of monoterpenes 
are generated from the precursor GPP which is formed 
by condensation of one molecule of IPP with one mol-
ecule of its isomer DMAPP (Fig. 1). Unlike plants, S. cer-
evisiae does not supply enough GPP for production due 
to the lack of a specific GPP synthase (GPPS). In S. cerevi-
siae, the ERG20 gene of the endogenous MVA pathway 
encodes a farnesyl pyrophosphate synthase (FPPS) that, 
despite having both GPP and FPP synthase activity, only 
releases a very low amount of GPP from its catalytic site 
[20]. To increase the flux to GPP, a set of ERG20 mutants 
was constructed to screen for GPPS preference mutants. 
ERG20K197G, the most effective mutant, improved geran-
iol production to 5 mg/L while expressing geraniol syn-
thase (GES) from Ocimum basilicum in S. cerevisiae [8]. 
Liu et  al. obtained 36  mg/L geraniol by overexpressing 
two key rate-limiting genes, tHMG1 encoding a trun-
cated version of 3-hydroxy-3-methylglutaryl coenzyme A 
and IDI1 encoding IPP isomerase, to enhance MVA path-
way flux and by overexpressing MAF1, a negative regula-
tor of MOD5 encoding tRNA isopentenyltransferase, to 
decrease the flux to tRNA biosynthesis [10]. In addition, 
Ignea et al. demonstrated that the double mutant Erg20p 
(F96W-N127W) had a strong dominant negative abil-
ity to decrease the FPPS function of Erg20p, increasing 
production of the monoterpene sabinene by 10.4-fold 
to 0.53  mg/L in an industrial diploid strain [16]. In our 
previous work, we further improved geraniol production 
through enhancing MVA pathway flux, screening differ-
ent sources of GESs and GPPSs, and designing fusion 
proteins of GES and GPPS. Geraniol of 293  mg/L pro-
duction was achieved in fed-batch cultivation, which is 
the highest monoterpene production in S. cerevisiae ever 
reported [21]. However, it is still lower than the produc-
tion of many other terpenes in S. cerevisiae [12, 22, 23].
In addition to the low GPP pool, the toxicity to micro-
organisms of monoterpenes also largely limits their 
microbial production [2, 24]. To alleviate the toxicity of 
monoterpenes, a two-phase fermentation system has 
been extensively applied by adding a non-toxic extractive 
solvent (e.g., dodecane) [2]. In addition, monoterpenols, 
usually undergo biotransformation to other terpenoids in 
aromatic plants, as well as in some wine yeasts [25, 26]. 
A recent study demonstrated that geraniol is converted 
into citronellol under the catalysis of the enzyme OYE2, 
and it is acetylated by ATF1 encoding alcohol acetyltrans-
ferase during wine fermentation by S. cerevisiae [27]. 
Fig. 1 Schematic overview of geraniol biosynthesis based on the 
mevalonate (MVA) pathway in S. cerevisiae. The endogenous genes 
tHMG1, IDI1 and ERG20WW and heterologous gene tVoGES encoding a 
truncated version of geraniol synthase from Valeriana officinalis were 
overexpressed to improve geraniol production in our previous work. 
The native promoter of ERG20 was replaced with the CTR3 promoter, 
BTS1 promoter or HXT1 promoter. Other engineered genes in this 
pathway: OYE2, NADPH oxidoreductase and ATF1, alcohol acetyl-
transferase. HMG-CoA 3-hydroxy-3-methylglutaryl coenzyme A, IPP 
isopentenyl pyrophosphate, DMAPP dimethylallyl pyrophosphate, 
GPP geranyl diphosphate, FPP farnesyl diphosphate
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Intracellular bioconversion of geraniol may be a self-
defense response to avoid the toxicity of monoterpenes. 
In addition, introduction of a heterologous biosynthetic 
pathway and the overexpression of an endogenous path-
way often lead to the accumulation of some intermediate 
metabolites, that may interfere with the native regulation 
of metabolic flux and increase metabolic burden, result-
ing in overproduction of some biosynthetic enzymes and 
accumulation of some toxic intermediate metabolites. 
Therefore, a dynamic control system that can sense envi-
ronmental changes such as metabolic intermediates or 
nutrient concentrations can be used to avoid the toxicity 
of intermediate metabolites [28–30].
Previously, we achieved a significant increase in geran-
iol production through expressing geraniol synthase 
from Valeriana officinalis and regulating GPP synthesis 
[21]. In this study, we further engineered strains through 
dynamic control of ERG20 to fine-tune the GPP flux 
combined with minimized geraniol endogenous conver-
sion. Combining these strategies together with LEU2 
auxotrophic complementation, the final geraniol produc-
tion reached 1.69 g/L in fed-batch fermentation, which is 
the highest reported production in yeast.
Results
Improving geraniol production by minimizing endogenous 
bioconversion
Geraniol is the main precursor of monoterpenoids in 
aromatic plants [4]. It also has many derivatives including 
nerol, neral, geranylgeraniol, geranial, citronellol and ter-
penyl acetates [31]. Previous studies have demonstrated 
that wine yeasts are able to convert geraniol into other 
monoterpenoids, which influence the sensory proper-
ties of wine [26, 32]. During S. cerevisiae fermentation, 
Oye2p is the main enzyme involved in the conversion of 
geraniol to citronellol, and Atf1p is the main contributor 
to synthesis of terpenyl acetates from geraniol [27]. In 
our early study, an efficient S. cerevisiae strain YZG13-
GE1 was constructed to produce geraniol from glucose 
through engineering of geraniol synthesis and optimiz-
ing GPP synthesis. To further improve geraniol produc-
tion, we attempted to minimize endogenous metabolism 
of geraniol in S. cerevisiae. Thus, we deleted OYE2 or 
ATF1 in YZG13-GE1 to create YZG14 or YZG15, respec-
tively. Batch fermentation was carried out in a two-phase 
fermentation system using dodecane as extractive sol-
vent. Geraniol was produced at 285.9  mg/L by YZG14 
with OYE2 deletion, which was improved by 1.7-fold 
compared with the control strain (YZG13-GE1), and 
259.8  mg/L was produced by YZG15 with ATF1 dele-
tion, which was improved by 1.6-fold compared with 
the control strain (YZG13-GE1) (Fig.  2a). The conver-
sion of geraniol to citronellol was decreased by 55% in 
YZG14 (Δoye2) (Additional file 1: Figure S1). In addition, 
we further investigated the effect of double deletion of 
OYE2 and ATF1 in YZG13-GE1 on geraniol production. 
The results showed that geraniol production dramati-
cally decreased to 32.2 mg/L in YZG16 with OYE2-ATF1 
deletions (Fig. 2a). Cell growth was not affected in either 
single gene deletion strain (Δoye2 or Δatf1) (Additional 
file  1: Figure S2), and geraniol yields were 57.8  mg/g 
DCW and 58.2  mg/g DCW, a 1.8-fold and 1.7-fold 
increase, respectively (Fig.  2b; Table  1). However, dou-
ble deletion of OYE2 and ATF1 decreased the final bio-
mass by 35%, and geraniol yield significantly dropped to 
9.6 mg/g DCW (Fig. 2; Table 1).
We also compared geraniol production in YZG14 
(Δoye2), YZG15 (Δatf1) and YZG16 (Δoye2Δatf1) in fed-
batch cultivation using glucose as sole carbon source. The 
Fig. 2 Production of geraniol by reducing endogenous conver-
sion of geraniol in batch fermentation. a Production of geraniol in 
engineered strains. b Cell growth of engineered strains. The data 
shown are representative of duplicate experiments, and the error bars 
represent the standard deviation
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cell growth of YZG14 (Δoye2) and YZG15 (Δatf1) exhib-
ited a similar growth profile compared with the reference 
strain YZG13-GE1. YZG14 (Δoye2) and YZG15 (Δatf1) 
produced 421.7 and 371.1  mg/L of geraniol, which rep-
resented approximately 2.5-fold and 2.2-fold increases 
relative to YZG13-GE1 (256.4  mg/L), respectively 
(Fig.  3). However, geraniol production was dramatically 
decreased in double deletion of OYE2 and ATF1 strain, 
only producing 46.1 mg/L geraniol (Fig. 3d).
The effect of ERG20 expression control on geraniol 
production
In S. cerevisiae, synthesis of both the monoterpene pre-
cursor GPP and sesquiterpene precursor FPP is catalyzed 
by a single enzyme, Erg20p, with FPP synthase prefer-
ence. In the absence of a specific GPP synthase, many 
efforts have been made to increase the intercellular GPP 
pool. Expression of heterologous GPP synthase does 
not increase the GPP-derived products significantly [16, 
21]. Although engineering Erg20p into a GPP synthase 
increased sabinene and geraniol production by 10.4-fold 
and 2.8-fold, respectively, the titer is still much lower 
than that of FPP-derived sesquiterpenes, demonstrating 
the importance of down-regulating FPP synthesis [10, 
16]. In this study, the native ERG20 promoter was first 
replaced with either the weak BTS1 promoter or the cop-
per repressible CTR3 promoter. YZG13-GE1 contain-
ing the native ERG20 promoter was used as a reference 
strain. The transcription level of ERG20 using the BTS1 
promoter or CTR3 promoter was reduced by 90 and 75% 
(Fig. 4a), respectively, in SD-URA-HIS medium with 2% 
glucose. Unexpectedly, the replacement of the ERG20 
promoter with that of BTS1 or CTR3 decreased geran-
iol production by 75.6 and 70.3%, resulting in 40.37 and 
48.85  mg/L, respectively (Fig.  4b). The BTS1 and CTR3 
promoters also decreased the final biomass by 60 and 
40% (Fig. 4c), repectively. Previously, we also found that 
overexpression of ERG20 reduced geraniol production 
[21]. These results demonstrated that both down-reg-
ulation and up-regulation of ERG20 have a negative 
impact on geraniol production. The dynamic control of 
ERG20 was then attempted by replacing the ERG20 pro-
moter with the glucose-sensing HXT1 promoter. This 
promoter strength is higher than that of ERG20 pro-
moter when glucose is present in the medium (Fig. 4a), 
but it is repressed when the glucose concentration is 
low or absent (Additional file  1: Figure S3). We found 
that the geraniol titer and final biomass were not mark-
edly affected by HXT1 promoter replacement in batch 
cultivation, and the yield of geraniol increased slightly 
(37.9 mg/g DCW vs. 32.7 mg/g DCW) (Table 1). Consid-
ering that the HXT1 promoter provides both high-glu-
cose induction and low-glucose repression, we attempted 
both glucose and glucose/ethanol (1:7) mixture feed-
ing strategies to control ERG20 expression in fed-batch 
fermentation. Compared with the control strain, HXT1 
promoter replacement did not increase geraniol produc-
tion when pure glucose was fed; geraniol production only 
increased slightly (data not shown). In contrast, when a 
glucose/ethanol (1:7) mixture was fed, the geraniol pro-
duction achieved a 176% increase in the HXT1 promoter 
replacement strain compared with the control strain, 
leading to 650.8 mg/L (Fig. 4d).
Previously, ethanol has been used as carbon for the 
production of hydrocortisone, amorpha-4,11-diene and 
resveratrol [33–35]. In this study, we further compared 
the impact of feeding different ratios of glucose and etha-
nol on geraniol production using YZG19 (PHXT1-ERG20). 
As shown in Fig.  5b, the cell growth of YZG19 (PHXT1-
ERG20) gradually improved as the ethanol percentage in 
glucose/ethanol mixture increased, and the final produc-
tion of geraniol also gradually increased. The highest pro-
duction of geraniol was obtained when pure ethanol was 
fed, producing 867.7  mg/L of geraniol (Fig.  5a). Based 
on the results described above, the dynamic control of 
ERG20 expression under the HXT1 promoter together 
with optimizing the glucose and ethanol ratio improved 
the production of geraniol by 3.8-fold.
Combining the dynamic control of ERG20 and reduction 
of endogenous conversion together with LEU2 
complementation enabled a further increase in geraniol 
production
To further improve geraniol production, we deleted the 
OYE2 gene in YZG19 (PHXT1-ERG20) to generate YZG20 
(Δoye2, PHXT1-ERG20), which produced 984.6  mg/L of 
geraniol in fed-batch fermentation by feeding ethanol, 
a 14% increase over YZG19 (PHXT1-ERG20) (Fig.  6a). A 
recent study showed that leucine metabolism may be 
networked with isoprenoid biosynthesis, and leucine pro-
totrophy was found to improve diterpenoid miltiradiene 
Table 1 Geraniol yield of  the engineered strains in  batch 
fermentation
a Duplicate experiments were performed for each strain, and the error bars the 
represented the standard deviation
Strainsa Dry cell weight (g/L) Geraniol yield 
(mg/g DCW)
YZG13-GE1 5.02 ± 0.31 32.69 ± 2.01
YZG14 (Δoye2) 4.94 ± 0.28 57.83 ± 3.24
YZG15 (Δatf1) 4.47 ± 0.22 58.16 ± 2.59
YZG16 (Δoye2Δatf1) 3.36 ± 0.34 9.58 ± 0.96
YZG17 (PBTS1-ERG20) 1.96 ± 0.10 20.58 ± 0.91
YZG18 (PCTR3-ERG20) 2.94 ± 0.23 16.61 ± 1.21
YZG19 (PHXT1-ERG20) 3.92 ± 0.26 37.87 ± 2.55
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production [36]. We further engineered a strain with 
complemented LEU2 auxotrophy, and final geraniol 
production was enhanced up to 1.69 g/L, a further 71% 
increase over YZG20 (Δoye2, PHXT1-ERG20). Meanwhile, 
we noticed that LEU2 complementation also improved 
cell growth and geraniol yield (Fig. 6b). The final geraniol 
production in this study was improved by 5.8-fold com-
pared with our previous study.
Discussion
Engineering S. cerevisiae as a cell factory is a promis-
ing and attractive route for rapid and inexpensive bio-
synthesis of terpenoids [12, 13, 22, 23, 34]. Over the last 
few years, most work has focused on the production 
of sesquiterpenes in microorganisms including S. cer-
evisiae. For instance, production of the sesquiterpene 
amorpha-4,11-diene, the precursor for the antimalarial 
agent artemisinin, has reached 40 g/L using engineered S. 
cerevisiae in fed-batch fermentation [12]. Both monoter-
penes and sesquiterpenes are derived from the MVA 
pathway. However, monoterpene production in S. cer-
evisiae is much lower than that of sesquiterpenes, mainly 
due to the poor GPP precursor supply and the toxicity 
of monoterpenes in yeast. In this work, we further engi-
neered production of the monoterpene geraniol through 
reduction of endogenous geraniol conversion, dynamic 
control of ERG20 expression and leucine biosynthesis 
complementation based on YZG13-GE1, a geraniol-pro-
ducing strain from our previous work [21]. Final geraniol 
production of 1.69 g/L was obtained, which to our knowl-
edge is the highest level reported for engineered yeast.
Monoterpenes are highly toxic to many microorgan-
isms. Cells may reduce their toxicity through the conver-
sion of monoterpenes to other lower toxicity compounds 
Fig. 3 Fed-batch fermentation of YZG13-GE1 (control) (a), YZG14 (Δoye2) (b), YZG15 (Δatf1) (c) and YZG16 (Δoye2Δatf1) (d). Aerobic fed-batch 
fermentations were carried out by feeding 400 g/L glucose at 0.1/h feed rate. The data shown are representative of duplicate experiments, and the 
error bars represent the standard deviation
Page 6 of 11Zhao et al. Microb Cell Fact  (2017) 16:17 
by various specific or non-specific enzymes. In our pre-
vious study, we confirmed that 180  mg/L of geraniol in 
culture could strongly inhibit yeast cell growth [21]. 
Although two-phase extractive fermentation could effec-
tively alleviate monoterpene toxicity in situ, the conver-
sion of monoterpenes to other terpenoids is not avoided 
completely. In S. cerevisiae, a mechanism was proposed 
in which geraniol was first oxidized to geranial by OYE2 
encoding an NADPH oxidoreductase and its homolo-
gous gene OYE3, belonging to the old yellow enzyme 
family, and then was reduced to citronellol [25, 27, 37]. 
However, the oxido-reductases involved in the reaction 
of geranial to citronellol are still unknown. Of the two 
old yellow enzymes, OYE2 was the main contributor to 
the reduction reaction. Except for citronellol, terpenyl 
acetates including citronellyl acetate and geranyl acetate 
are another group of geraniol-derived metabolites cata-
lyzed by ATF1 encoding alcohol acetyltransferase. In our 
study, deletion of OYE2 or ATF1 led to a 1.8-fold increase 
of geraniol production. Interestingly, the ATF1 deletion 
strain increased citronellol production compared with 
the control strain (Additional file  1: Figure S1). A simi-
lar phenomenon was observed in a previous study, which 
indicated that there may be a relationship between the 
physiological functions of OYE2 and ATF1. Although the 
old yellow enzymes in yeast may have a physiological role 
Fig. 4 Production of geraniol in ERG20 promoter replacement strains. a Transcription level of ERG20 controlled by different promoters. b Production 
of geraniol in engineered strains in batch fermentation. c Cell growth of engineered strains in batch fermentation. d Geraniol production in YZG13-
GE1 and HXT1 promoter replacement strain (YZG19) in fed-batch fermentation. All strains were grown in SD medium with 2% glucose, and the cells 
were collected when OD600 reached 0.6 to extract mRNA for ERG20 mRNA and transcription determination. Aerobic fed-batch fermentations were 
carried out by feeding a 50 g/L glucose and 350 g/L ethanol (1:7) mixture at 0.1/h feed rate. The data shown are representative of duplicate experi-
ments, and the error bars represent the standard deviation
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in detoxification of unsaturated metabolites and reac-
tive oxygen species, both OYE2 and ATF1 are thought 
to be involved in sterol metabolism [38, 39]. Therefore, 
functional complementation in the regulation of sterol 
metabolism between OYE2 and ATF1 may be a reason for 
the lower cell growth and geraniol production in the dou-
ble deletion strain.
In the geraniol-producing engineered S. cerevisiae, 
the reaction catalyzed by ERG20 is a key branch point 
towards either geraniol synthesis or downstream ergos-
terol synthesis for cell growth. Although ERG20 muta-
tions could improve monoterpene production, the 
reduction of intercellular FPP synthesis damaged cell 
growth [8, 16]. In this study, the weak promoter PBTS1 and 
the copper-repressible promoter PCTR3 were first tested 
for ERG20 down-regulation to redirect GPP flux. The 
transcriptional level of ERG20 in the promoter replace-
ment strains was decreased to a one-fifth to one-sixth, 
and reduced cell growth was also observed when geran-
iol synthase and the MVA pathway were overexpressed 
in promoter replacement strains (Fig.  4; Additional 
file 1: Figure S4). The enhancement of the MVA pathway 
together with ERG20 down-regulation possibly led to the 
accumulation of toxic intermediates such as DMAPP or 
GPP. The toxicity of isoprenoid precursors has also been 
reported in E. coli and Bacillus subtilis [40–42]. Previ-
ously, we found that although overexpression of ERG20 
did not affect growth, it decreased geraniol production. 
Therefore, neither up-regulation or down-regulation 
of ERG20 was able to increase geraniol production. A 
suitable ERG20 expression strategy that can weaken the 
downstream FPP flux but not impair cell growth to fur-
ther improve geraniol production in engineered yeast is 
needed. To achieve this goal, dynamic control of ERG20 
is proposed, which is likely to not only balance metabo-
lism between product formation and cell growth, but also 
prevent the accumulation of toxic metabolites. Recently, 
several dynamic control systems have been developed 
and applied in metabolic engineering, i.e., a biosensor 
(sensor-regulator) system [43], a sequential control sys-
tem based on the medication GAL regulation system 
combined with the HXT1 promoter [23] and a novel 
CRISPR-Cas9 interference system [44]. To avoid early 
accumulation of toxic intermediates and to better balance 
the utilization of GPP, PHXT1, a glucose-sensing promoter, 
was employed to dynamically control ERG20 expres-
sion in our study. An HXT1 promoter replacement strain 
(YZG19) did not contribute to improve geraniol produc-
tion in batch or fed-batch fermentation using glucose as 
sole carbon, but its advantage appeared when the glucose 
concentration was low (feeding glucose/ethanol mixture 
carbon). The geraniol production improved stepwise 
when the glucose percentage decreased in the glucose/
ethanol mixture (Figs.  4, 5). These results indicate that 
the dynamic control of ERG20 expression by the HXT1 
promoter can balance the flux distribution between cell 
growth and monoterpene synthesis, thus improving 
geraniol production with low glucose feeding (Fig. 5). In 
addition, ethanol feeding possibly improved the geraniol 
production to some extent due to supplying acetyl-CoA 
precursors in a more direct metabolic pathway. An etha-
nol feeding strategy has also been successfully applied in 
amorphadiene and resveratrol production [34, 35].
Finally, strategies combining the OYE2 deletion and 
PHXT1-controlled ERG20 expression further improved 
Fig. 5 The effect of different carbon sources on geraniol produc-
tion by YZG19 (PHXT1-ERG20) in fed-batch fermentation. a Production 
of geraniol by YZG19. b Cell growth of YZG19. Aerobic fed-batch 
fermentations were carried out by feeding different ratios of glucose 
and ethanol at 0.1/h feed rate. The data shown are representative 
of duplicate experiments, and the error bars represent the standard 
deviation
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geraniol production to 984.6  mg/L (Fig.  6). A previous 
report showed that leucine metabolism may be net-
worked with sterol biosynthesis, and that leucine was dis-
assimilated to form HMG-CoA in Leishmania mexicana 
[45]. In S. cerevisiae, the leucine biosynthetic pathway 
may act as a bypass pathway to supplement additional 
HMG-CoA. Therefore, we further constructed the proto-
trophic strain YZG21 by complementing the auxotrophic 
marker LEU2. The LEU2 complementation ultimately 
improved the geraniol production to 1.69 g/L, meanwhile 
also improving cell growth and yield. A similar result was 
observed in a previous study on miltiradiene production 
[36].
Although a relatively high level of geraniol was 
obtained in our work, the cytotoxicity of monoterpe-
nes is still considered as a problem that hinders further 
improvement of monoterpene production. Improving 
the resistance of microorganisms to monoterpenes still 
needs to be addressed to further enhance the monoter-
pene production. In addition, diploidization is another 
potential strategy for improving biomass and productiv-
ity given that diploid strains generally grow faster and 
tolerate higher stresses compared with haploid strains 
[36, 46]. More importantly, constructing a plasmid-free 
geraniol overproducing strain by integration of all path-
way components into the genome is necessary for appli-
cation in industrial processes.
Conclusions
In summary, we engineered geraniol biosynthesis 
through the reduction of endogenous geraniol conversion 
and dynamic control of ERG20 expression. In addition, 
we further identified the importance of LEU2 comple-
mentation to geraniol synthesis. Ultimately, 1.69  g/L of 
geraniol was achieved when these approaches were com-
bined in fed-batch fermentation with pure ethanol feed-
ing. The present work provides a good platform for the 
production of geraniol and its derived chemicals.
Methods
Medium
The E. coli strain Tans5α was used for gene cloning and 
grown in Luria–Bertani medium (5  g/L yeast extract, 
10  g/L tryptone, and 10  g/L NaCl) supplemented with 
100 mg/L ampicillin at 37 °C. The engineered yeast strain 
YZG13-GE1 constructed in our previous work was used 
as the parent strain for further engineering [21]. Yeast 
cells were cultivated in yeast extract-peptone-dextrose 
(YPD) medium (20  g/L glucose, 20  g/L tryptone, and 
10 g/L yeast extract), SD-URA or SD-URA-HIS medium 
(20  g/L glucose, 1.7  g/L yeast nitrogen base, and 5  g/L 
(NH4)2SO4; synthetic complete drop-out medium 
without uracil and/or histidine). Geneticin (G418) at 
400  mg/L was added to the culture medium for gene 
deletion and promoter replacement.
DNA manipulation and strain construction
All yeast strains constructed in this study are listed in 
Table  2. The reference strain is YZG13-GE1, which is 
derived from CEN.PK102-5B and harbored pZGV6-
GE1 (2µ ori, URA3, PTEF1-tVoGES-(GGGS)-ERG20WW) 
and pZMVA4 (2µ ori, HIS3, PTEF1-tHMG1, PPGK1-IDI1, 
PTEF1-UPC2.1) [21]. The primers for all DNA fragment 
amplifications are listed in Additional file  1: Table S1. 
Fig. 6 Fed-batch fermentation of YZG20 (Δoye2, PHXT1-ERG20) (a) and YZG21 (LEU2, Δoye2, PHXT1-ERG20) (b) using pure ethanol feeding. Aerobic fed-
batch fermentations were carried out by feeding 400 g/L ethanol with 0.1/h feed rate. The data shown are representative of duplicate experiments, 
and the error bars represent standard deviations
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To replace the ERG20 promoter with different promot-
ers, integration cassettes were constructed via fusion 
PCR using loxp-kanMX-loxp as the selection marker. 
The BTS1 promoter (from −1 to −333), CTR3 promoter 
(from +30 to −1116), and HXT1 promoter (from −1 to 
1190) replaced the ERG20 promoter in the chromosome 
[23, 47, 48]. Similarly, the deletions of genes ATF1 and 
OYE2 were also performed through homologous recom-
bination using loxp-kanMX-loxp as the selection marker. 
The LEU2 cassette was integrated into the YPRCτ3 site of 
the chromosome. The DNA fragments were transformed 
into S. cerevisiae CEN.PK102-5B by the standard lithium 
acetate method [49], and the transformants were selected 
on YPD agar plates supplemented with 400 mg/L gene-
ticin (G418). The plasmid pSH47 (purchased from Euro-
scarf ) was transformed into S. cerevisiae to remove the 
selection marker. The engineered strains were then trans-
formed with plasmids pZGV6-GE1 and pZMVA4, result-
ing in a series of geraniol-producing strains (Table 2).
Batch and fed‑batch fermentation for geraniol production
To determine the performance of the recombinant yeast 
strains, batch fermentation and fed-batch fermentation 
were performed in a 1-L Infors-HT fermenter (Infors 
AG, Bottmingen, Switzerland). To prepare seed cultures, 
the strains were grown for 24 h in 5 mL of SD-URA-HIS 
medium, and then inoculated into fresh SD-URA-HIS 
medium at an OD600 of 0.2 and cultivated for 12  h. For 
batch fermentation, a seed culture was inoculated into a 
1-L Infors-HT fermenter (Infors AG, Bottmingen, Swit-
zerland) containing 0.6 L of SD-URA-HIS medium at 
an initial OD600 of 0.2. Batch cultures were conducted at 
30  °C, with the agitation rate at 600 rpm and an airflow 
rate of 1 vvm. The pH was maintained at 5.0 by auto-
matic addition of 2.5  M NaOH. Dissolved oxygen was 
maintained above 30% saturation throughout cultivation 
by setting the stirring speed rate. For fed-batch cultiva-
tion, strains were first grown in a 400-mL batch culture 
at 30  °C with shaking at 600  rpm, an airflow rate of 1 
vvm and pH 5.0. After the glucose and ethanol produced 
in the batch phase were depleted, feeding solution con-
taining 400 g/L glucose, 100 g/L (NH4)2SO4, 34 g/L yeast 
nitrogen base, 1.3  g/L CSM-Ura-His, and 2  g/L leucine 
was fed to the fermenter at a controlled specific feed rate 
of 0.1/h. Feeding of a glucose/ethanol mixture or pure 
ethanol was also used for strains in which the ERG20 
promoter was replaced with the HXT1 promoter to 
control ERG20 expression. In both batch and fed-batch 
cultures, 20% dodecane was added to the medium after 
cultivating for 12 h for geraniol extraction. Independent 
duplicate cultures were conducted for each strain.
RNA extraction and quantitative real‑time PCR
Total RNA was prepared from 40  mL exponentially 
growing cell cultures using the UNIQ-10 Trizol RNA 
extraction kit (Sangon Biological Engineering, Shanghai, 
Table 2 Strains used in this study
Strain name Parent strain Plasmids/genotype Source
CEN.PK102-5B MATa ura3-52 his3Δ1 leu2-3,112 Dr. P. Kötter, Frankfurt, Germany
5B-Δoye2 CEN.PK102-5B Δoye2::loxP This study
5B-Δatf1 CEN.PK102-5B Δatf1::loxP This study
5B-Δoye2Δatf1 CEN.PK102-5B Δoye2::loxP, Δatf1::loxP This study
5B-PBTS1 CEN.PK102-5B ΔPERG20::loxP-PBTS1 This study
5B-PCTR3 CEN.PK102-5B ΔPERG20::loxP-PCTR3 This study
5B-PHXT1 CEN.PK102-5B ΔPERG20::loxP-PHXT1 This study
5B-Δoye2-PHXT1 5B-PHXT1 ΔPERG20::loxP-PHXT1, Δoye2::loxP This study
5B-LEU2-Δoye2-PHXT1 5B-Δoye2-PHXT1 ΔPERG20::loxP-PHXT1, ΔYPRCtau3::PLEU2-LEU2-TLEU2-loxP This study
YZG13-GE1 CEN.PK102-5B pZGV6-GE1, pZMVA4 [21]
YZG14 5B-Δoye2 pZGV6-GE1, pZMVA4 This study
YZG15 5B-Δatf1 pZGV6-GE1, pZMVA4 This study
YZG16 5B-Δoye2Δatf1 pZGV6-GE1, pZMVA4 This study
YZG17 5B-PBTS1 pZGV6-GE1, pZMVA4 This study
YZG18 5B-PCTR3 pZGV6-GE1, pZMVA4 This study
YZG19 5B-PHXT1 pZGV6-GE1, pZMVA4 This study
YZG20 5B-Δoye2-PHXT1 pZGV6-GE1, pZMVA4 This study
YZG21 5B-LEU2-Δoye2-PHXT1 pZGV6-GE1, pZMVA4 This study
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China). The samples were digested using DNase I treat-
ment (TakaRa, Dalian, China) to avoid DNA contamina-
tion. The treated total RNA was used for cDNA synthesis 
using the PrimeScript RT-PCR Kit (TakaRa, Dalian, 
China). qPCR was performed using the SYBR Green 
Master Mix Kit (Roche Molecular Biochemicals, Ger-
many). The ACT1 gene was chosen as the internal control 
gene. The relative transcription levels of genes were ana-
lyzed using the 2−ΔΔCT method.
Analysis of metabolites by HPLC
At each 12-h interval, the cultures were sampled and 
centrifuged at 12,000 rpm for 5 min. The filtered samples 
were analyzed using an HPLC equipped with an Aminex 
HPX-87H ion-exchange column (Bio-Rad, Hercules, 
CA, USA) at 45 °C with a mobile phase of 5 mM H2SO4 
at a flow rate of 0.6  mL/min. The peaks of metabolites 
including glucose, ethanol, acetic acid and glycerol were 
detected by refractive index (RI) and ultraviolet (UV) 
detectors.
Characterization of geraniol and citronellol by GC–MS
To quantify titers of geraniol and citronellol in different 
cultures, 1 mL of the upper layer (dodecane/culture mix-
ture) was sampled and concentrated at 13,000  rpm for 
5 min to separate the dodecane phase, and then the dode-
cane layer was transferred into a GC vial and stored at 
−20  °C for analysis. The residual geraniol was extracted 
again by adding 10% (v/v) dodecane into the medium. 
Geraniol and citronellol were identified using a GC–MS 
system (Shimadzu Co., Kyoto, Japan) equipped with an 
HP-5 ms capillary column (30 m × 0.25 mm × 0.25 µm), 
an AOC-20i auto-injector, and a QP-2010 mass detec-
tor, and the operational conditions were as follows. One 
microliter of each dodecane sample was injected into the 
system with a split ratio of 10 and the carrier gas helium 
was set at a constant flow rate of 0.78 mL/min. The oven 
temperature was first maintained at 60 °C for 2 min, and 
then gradually increased to 150 °C at a rate of 10 °C/min, 
held for 10 min, and finally increased to 230 °C at a rate 
of 20  °C/min and held for 5  min. The mass spectrome-
ter was set to SIM acquisition mode, scanning m/z ions 
within the range 40–500 for identification of geraniol and 
citronellol. The total run time was 30 min. Standard com-
pounds of geraniol and citronellol (Sigma-Aldrich) were 
dissolved in dodecane and used to plot standard curves 
for quantification.
Biomass determination
Optical density at 600  nm (OD600) was measured using 
a spectrophotometer (Eppendorf AG, 22331 Hamburg, 
Germany). Dry cell weight (DCW) was obtained from 
OD600 measurement after calibration as indicated before 
(1 g/L biomass = 0.246× (OD600)− 0.0012) [50].
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